Müzeyyen Eryılmaz

Dr. Müzeyyen Eryılmaz

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AKAli Kirik
Ali Kirik
Hilmi Erdem SumbulHilmi Erdem Sumbul
Hilmi Erdem Sumbul
Nizameddin KocaNizameddin Koca
Nizameddin Koca
TKTurkan Pasali Kilit
Turkan Pasali Kilit
SSsibel demiral sezer
sibel demiral sezer
TDTeoman Doğru
Teoman Doğru
Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) prevalence data in Türkiye is limited. We aimed to determine the nationwide prevalence of MASLD and advanced hepatic fibrosis risk in subjects with cardiometabolic risk factors (CMRF). Despite recent international consensus redefining fatty liver disease terminology, no nationwide MASLD study has been reported in Türkiye. Methods: This cross-sectional study included 14,371 adults with ≥1 CMRF from 44 centers across 31 cities. MASLD was diagnosed using liver ultrasonography plus cardiometabolic criteria. Advanced fibrosis risk was assessed by fibrosis-4 (FIB-4) score (≥1.3 for ≤65 years; ≥2.0 for >65 years). Logistic regression was used to identify independent predictors of high FIB-4. Results: A total of 61.4% of participants were women, the mean age was 51.3 ± 14.4 years, and the mean BMI was 31.4 ± 6.0 kg/m2. MASLD prevalence was 75.7% (n = 10,873), rising with the number of CMRFs (56.5% with one factor vs. 83.4% with all). The prevalence of high FIB-4 scores was 12.0% overall, being lower in MASLD patients than non-MASLD patients (11.2% vs. 14.4%, p < 0.001). FIB-4 scores decreased with increasing BMI (28.1% underweight vs. 8.7% class III obesity). Male sex, T2DM, and hypertension independently predicted high FIB-4 scores, while smoking, higher BMI, and MASLD were inversely associated. Conclusions: Three-quarters of Turkish adults with CMRF have MASLD. Standard FIB-4 thresholds may underestimate fibrosis risk in obese and smoking populations, underscoring the need for adjusted cut-offs or alternative tools. This study is the first to provide nationwide MASLD prevalence data in Türkiye.

17 October 2025 in BMC Ophthalmology
Verified
Journal Article
Open access
PDF file
NSNeslihan Sevimli
Neslihan Sevimli
MEMüzeyyen Eryılmaz
Müzeyyen Eryılmaz
MAMuhammed Kaan Azarbaz
Muhammed Kaan Azarbaz
GTGüneş Taydaş
Güneş Taydaş
To evaluate Schlemm’s canal (SC) dimensions and choroidal vascularity in patients with Graves’ orbitopathy (GO+), and to compare the findings with those of patients with Graves’ disease (GD) without orbitopathy (GO-) and healthy controls using optical coherence tomography (OCT); additionally, to investigate the potential impact of these anatomical and vascular changes on intraocular pressure (IOP) elevation and glaucoma susceptibility. This cross-sectional study included 164 participants, categorized into three groups: GO+ (n = 38), GO- (n = 76), and healthy controls (n = 50). All subjects were euthyroid for at least six months. SC length (SCL), SC area (SCA), choroidal vascularity index (CVI), luminal area (LA), stromal area (SA), and total choroidal area (TCA) were assessed. Correlations between SCA, SCL, and CVI measurements and other ocular and systemic parameters were analyzed. Demographic, ocular, and systemic parameters were also compared among groups. There were no significant differences in age, sex, intraocular pressure, central corneal thickness, retinal nerve fiber layer thickness, or optic disc parameters across groups (p > 0.05). Hertel exophthalmometry values were significantly elevated in the GO + group (p < 0.001). Both SCL and SCA were significantly lower in the GO + group compared to the GO- and control groups (p < 0.001). The GO- group showed significantly reduced SC measurements compared to controls (p < 0.001). While CVI did not differ significantly among groups (p = 0.758), pairwise analysis revealed significantly higher LA (p = 0.028) and TCA (p = 0.035) levels in the GO + group compared to the GO- group. A borderline correlation was observed between SCA and CVI (r = 0.150, p = 0.050), and a significant negative correlation was noted between Hertel values and SCA (r = − 0.394, p < 0.001). Changes in SC and choroidal structures in GD may be influenced by both mechanical and systemic factors. While these alterations may contribute to IOP elevation, they do not directly imply increased glaucoma risk but could play a role in its development or progression in susceptible individuals.

22 April 2026 in Cyprus Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
MEMüzeyyen Eryılmaz
Müzeyyen Eryılmaz
AGArzu Güntürk
Arzu Güntürk
KYKadir Yılmaz
Kadir Yılmaz
Comparative Diagnostic Utility of Systemic Inflammatory Indices Across Hyperthyroidism Subgroups - Cyprus Journal of Medical Sciences

29 June 2021
Verified
Book
Closed access
PDF file
SKSabiha Kömoğlu
Sabiha Kömoğlu
SUsongül usalp
songül usalp
AEAhmed Serkan Emekli
Ahmed Serkan Emekli
IEİnCi Emekli
İnCi Emekli
AGArzu Güntürk
Arzu Güntürk
GÖGülcan Öztürk
Gülcan Öztürk

21 August 2026 in Medicine
Verified
Journal Article
Open access
IKIlkay Keskinel
Ilkay Keskinel
MEMüzeyyen Eryılmaz
Müzeyyen Eryılmaz
AFAsuman Akkaya Firat
Asuman Akkaya Firat
Histamine is a central mediator in immunoglobulin E (IgE)-mediated allergic responses, and diamine oxidase (DAO) contributes to extracellular histamine degradation. Altered histamine metabolism has been proposed as a potential modifier of symptom burden in atopic conditions. However, whether circulating DAO protein concentrations differ in patients with allergic asthma and/or allergic rhinitis remains unclear. This study aimed to compare serum DAO concentrations between patients with allergic asthma and/or allergic rhinitis and healthy controls and to examine their associations with immunological and respiratory parameters. In this cross-sectional study, 141 patients with allergic asthma and/or allergic rhinitis and 78 healthy controls were enrolled between January 1, 2025, and March 1, 2025. Serum DAO protein concentrations were measured using enzyme-linked immunosorbent assay. Additional assessments included total IgE, eosinophil count, eosinophil cationic protein, and spirometric parameters. Statistical analyses comprised group comparisons, Spearman's correlation analysis, and receiver operating characteristic curve analysis. Median serum DAO concentrations were significantly lower in patients with allergic asthma and/or allergic rhinitis than in healthy controls (13.8 U/mL vs 28.2 U/mL; P < .001). DAO levels were not significantly correlated with age, sex, total IgE, eosinophil indices, eosinophil cationic protein, or pulmonary function parameters. Receiver operating characteristic analysis demonstrated good discriminatory performance (area under the curve = 0.84, 95% confidence interval = 0.79–0.89; P < .001). The optimal cut-off value of 22.2 U/mL yielded 80% sensitivity and 87% specificity, although this threshold requires external validation. Circulating DAO protein concentrations were reduced in patients with allergic asthma and/or allergic rhinitis compared with healthy individuals. Given the cross-sectional design and the lack of direct enzymatic activity assessment, the results should be interpreted as hypothesis-generating. Prospective studies are warranted to clarify the clinical relevance of DAO measurement in allergic diseases.

29 April 2026 in European Journal of Medical Research
Verified
Journal Article
Open access
AYARZU YALÇIN
ARZU YALÇIN
MEMüzeyyen Eryılmaz
Müzeyyen Eryılmaz
KYKadir YILMAZ
Kadir YILMAZ